
Medical News
Contact Us

Umbilical Cord‐Derived Therapies for Wound Healing: A Scoping Review of Clinical and Translational Evidence
Experimental dermatology, 06/09/2026 Introduction Wound Healing Wound healing consists of 4 stages: hemostasis, inflammation, proliferation, and remodeling. Hemostasis occurs immediately after injury with vasoconstriction, platelet

Effects of Wharton’s Jelly-Derived Mesenchymal Stem Cell Secretome on Human Endometrial Cell Function
Journal of Neuroinflammation, August 24, 2026 Background & Research Objectives Background: Chronic Obstructive Pulmonary Disease (COPD) is frequently accompanied by neurocognitive disorders (COPD-NCDs), which severely

UofL cardiologist leading clinical trial for high potential new therapy for heart failure
University of Louisville Foundation, 06/08/2026 Multicenter trial of adult stem cells derived from donated umbilical cords is first in U.S. to test this therapy and

Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study
Stem Cells Translational Medicine, 05/08/2026 Introduction Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that causes synovial inflammation and can lead to joint destruction

FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
FDA, 27/06/2026 Room-temperature-stable and rapidly reconstituted, this first FDA-licensed product brings new options to emergency and remote settings. The U.S. Food and Drug Administration today

Platelet-rich plasma for non-invasive closure of tracheal and bronchial fistulas: a case series
Research Connections, 16/07/2026 Introduction Airway fistulas, including tracheoesophageal fistula (TEF) and bronchopleural fistula (BPF), are serious complications associated with prolonged mechanical ventilation, thoracic surgery, malignancy,

Red Blood Cells for Premature Babies: A Product from Cord Blood Banks
Parent’s Guide to Cord Blood, July 2026 This is a story about turning trash into treasure. Traditionally, cord blood banks separate cord blood into three

Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives
Stem Cell Reviews and Reports, 16/07/2026 Introduction Non-alcoholic fatty liver disease (Non-Alcoholic Fatty Liver Disease – NAFLD) was previously the primary term for chronic liver

Mesenchymal stem cell therapy as adjunctive treatment in pediatric patients with severe acquired brain injury: a single-center retrospective case series
Frontiers in Pediatrics, 14/07/2026 Introduction Severe acquired brain injury (SABI) is a leading cause of mortality and long-term neurological disability in children. Current management in

Unrelated cord blood transplantation for pediatric patients with inborn error of immunity and inborn error of metabolism in Vietnam: early single-center experience
Frontiers in Immunology, 10 July 2026 SUMMARY: Research published in the international journal Frontiers in Immunology (July 2026) shows that unrelated cord blood transplantation (UCBT)